Vertex’s Kaftrio approved for use in Europe and made accessible on the NHS
The European Commission and European Medicines Agency have approved the triple combination Kaftrio for use in certain cystic fibrosis...
Age May Affect Outcomes in Lung Transplant Recipients With Cystic Fibrosis
Age may influence outcomes in lung transplant recipients with cystic fibrosis (CF), according to study results published in the Annals of...
CFF Funding Will Further ContraFect’s Research Into Alternative for Antibiotics
ContraFect will receive funding from the Cystic Fibrosis Foundation to conduct preclinical research about the potential of direct lytic...
The search for molecular glue in targeted disease control
In cells, there are proteins that do the work and proteins that regulate them. The latter inhibit or enhance activity, depending on the...
Vest Therapy Lowers Risk of Hospitalization in Non-CF Bronchiectasis, Study Says
One year of vest therapy with high frequency chest wall oscillation (HFCWO) can reduce the risk of hospitalization and the use of...
Harvard is working with Boston hospitals to test existing cystic fibrosis drug to help coronavirus p
Researchers at Harvard University announced this week it will begin examining if an existing drug used to treat cystic fibrosis could...
Eleven medicines backed for EU approval
The European Medicines Agency human medicines committee (CHMP) has backed eleven medicines for approval at its July 2020 meeting,...
Glycosaminoglycans as Multifunctional Anti-Elastase and Anti-Inflammatory Drugs in Cystic Fibrosis L
Neutrophil elastase (NE) is a major protease in the airways of patients with cystic fibrosis (CF) that activates airway inflammation by...
Urine Marker Could Help in Screening for CF Lung Infections, Study Finds
Measuring levels of a molecule called lipoarabinomannan, or LAM, in a person’s urine could be an easier way of screening for airway...
Arrowhead Pharmaceuticals Hosts Key Opinion Leader Webinar on ARO-ENaC for Treatment of Cystic Fibro
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) is hosting a key opinion leader webinar today at 12:00...
